Although a genetical test for APOE cannot replace any part of the clinical diagnostic procedure [35, 74, 75], including the patient’s APOE carrier status improves prediction accuracy of diagnostic tests such as memory tests or MR imaging in individuums who meet clinical MCI or AD criteria [8, 24, 76–78]. The gene discussed is APOE; the disease is Alzheimer disease.